Status:
COMPLETED
The Cognitive and spOrt Virtual EPIC Training Study for Cardiovascular Diseases
Lead Sponsor:
Montreal Heart Institute
Conditions:
Cardiovascular Diseases
Eligibility:
All Genders
50-100 years
Phase:
NA
Brief Summary
COVEPICARDIO trial is designed to document the effects of remote monitoring of physical exercise and home-based cognitive training on cognitive and physical functions in older adults with cardiovascul...
Detailed Description
Cardiac rehabilitation is a class I level A recommendation with clinical benefits that are now well documented. Due to the COVID-19 pandemic, accessibility to rehabilitation services and exercise trai...
Eligibility Criteria
Inclusion
- Adults aged 50 and older
- Have access to internet
- Have access to a tablet (i.e., iPad or Android) or a computer
- Diagnostic of cardiovascular disease (stable chronic systolic or diastolic heart failure, atrial fibrillation, documented atherosclerotic disease).
- Able to do light to moderate aerobic exercice training
- With no contraindication to exercise training
Exclusion
- Non-cardiopulmonary limitation to exercise (e.g., arthritis)
- Severe exercise intolerance
- Respiratory disease (e.g., asthma, COPD, COVID-19)
- Mini Mental Scale Examination (MMSE) telephone version lower than 19/23
Key Trial Info
Start Date :
May 18 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2022
Estimated Enrollment :
122 Patients enrolled
Trial Details
Trial ID
NCT04661189
Start Date
May 18 2020
End Date
December 1 2022
Last Update
November 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Preventive medicine and physical activity centre (centre EPIC), Montreal Heart Institute
Montreal, Quebec, Canada, H1T1N6